A Response To: Letter to the Editor Regarding "Comparing Cardiovascular Outcomes and Costs of Perindopril-, Enalapril- or Losartan-Based Antihypertensive Regimens in South Africa: Real-World Medical Claims Database Analysis"
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Wang S, Sreedhara S, Schneeweiss S
. Reproducibility of real-world evidence studies using clinical practice data to inform regulatory and coverage decisions. Nat Commun. 2022; 13(1):5126.
PMC: 9430007.
DOI: 10.1038/s41467-022-32310-3.
View
2.
Saesen R, Van Hemelrijck M, Bogaerts J, Booth C, Cornelissen J, Dekker A
. Defining the role of real-world data in cancer clinical research: The position of the European Organisation for Research and Treatment of Cancer. Eur J Cancer. 2023; 186:52-61.
DOI: 10.1016/j.ejca.2023.03.013.
View
3.
Dang A
. Real-World Evidence: A Primer. Pharmaceut Med. 2023; 37(1):25-36.
PMC: 9815890.
DOI: 10.1007/s40290-022-00456-6.
View
4.
Cave A, Kurz X, Arlett P
. Real-World Data for Regulatory Decision Making: Challenges and Possible Solutions for Europe. Clin Pharmacol Ther. 2019; 106(1):36-39.
PMC: 6617710.
DOI: 10.1002/cpt.1426.
View
5.
de Lusignan S, Crawford L, Munro N
. Creating and using real-world evidence to answer questions about clinical effectiveness. J Innov Health Inform. 2015; 22(3):368-73.
DOI: 10.14236/jhi.v22i3.177.
View